Weve got a good crowd
Whats more, Comesana even had the cheek to ask the umpire if he could light it for him
He receives consultancy fees from Pfizer, Boehringer Ingelheim, Duska Therapeutics, Forest Laboratories, CV Therapeutics, Sermo Inc., GRG Health, Clarivate Analytics, Guidepoint Expert Network, and GLG Group
Since the proposed payment methodology for the new add-on code for Opvee (GOTP1), the weekly bundled payment for weekly Brixadi (GOTP2), and the update to the monthly bundled payment for injectable buprenorphine (HCPCS code G2069) is based on comparable and existing drugs billed under the Medicare OTP benefit, and assuming an OTP may provide these new drugs to a Medicare beneficiary in lieu of the comparable ( and existing drugs under the Medicare OTP benefit ( e.g., Opvee instead of Narcan or Kloxxado, or the weekly or monthly formulation of Brixadi instead of Sublocade), then CMS estimates the financial impacts of these new drugs would be negligible
Here's a look at the issues, science, and perspectives: SMOKING POT VS
